Galapagos NV
GLPG
#4961
Rank
C$2.60 B
Marketcap
C$38.79
Share price
0.00%
Change (1 day)
-1.09%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): C$0.75 Billion

According to Galapagos NV's latest financial reports the company's current earnings are C$1.22 Billion. In 2025 the company made an earning of C$0.51 Billion, an increase over its 2024 earnings that were of -C$8.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.75 B46.35%
2025 C$0.51 B-6464.81%
2024 -C$8.09 Million-82.77%
2023 -C$46.93 Million-85.59%
2022 -C$0.33 Billion60.71%
2021 -C$0.21 Billion-60.08%
2020 -C$0.51 Billion-331.44%
2019 C$0.21 B-523.76%
2018 -C$51.77 Million-72.34%
2017 -C$0.19 Billion-329.59%
2016 C$81.52 M-144.3%
2015 -C$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.34 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.38 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$9.22 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.71 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$18.39 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.51 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$14.00 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-C$74.81 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.17 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel